KPI-121 1%

· Kala Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KPI-121 1%, covering 2020-04-07 to 2020-04-07. Get the full timeline:

Most recent: Clinical Trial Update: KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children [Phase 3]